Overview

A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects

Status:
Completed

Trial end date:
2009-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether the combination of naltrexone SR and bupropion SR is safe and effective in the treatment of obesity.

Phase:

Phase 3

Details

Lead Sponsor:

Orexigen Therapeutics, Inc

Treatments:

Bupropion
Naltrexone